How many migraine patients need prolonged(>1 year) preventive treatment? Experience with topiramate

Journal of Headache and Pain

Volumn 8, Issue 2, 2007, Pages 90-93

  Pascual, Julio ^a   el Berdei, Yasmina ^a   Gómez Sánchez, José C ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Migraine; Preventive treatment; Topiramate

Indexed keywords

TOPIRAMATE;

ADULT; AGED; ARTICLE; ASTHENIA; BODY WEIGHT; COGNITIVE DEFECT; DISTAL PARESTHESIA; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

ADULT; AGED; FEMALE; FRUCTOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249081663     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-007-0351-x     Document Type: Article

References (13)

1. Lipton RB, Scher AI, Kolodner K et al (2002) Migraine in the United States: Epidemiology and patterns of health care use. Neurology 58:885-894
2. Silberstein SD (2000) Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754-762
3. Steiner TJ, MacGregor EA, Davies PTG (Writing Committee) (2004) Guidelines for all doctors in the diagnosis and management of migraine and tension-type headache, 2nd Edn (revised August). Available at www.bash.org.uk
4. Tfelt-Hansen P (2006) Prioritizing prophylactic treatment of migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott Williams & Wilkins, Philadelphia pp 567-568
5. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24[Suppl 1]:8-160
6. Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742-746
7. Pascual J, Sánchez del Río M, Mateos V et al (2003) Topiramate for patients with refractory migraine: An observational, multicenter study in Spain. Neurología 18:428-432
8. Peres MFP, Mercante JPP, Tanuri FC, Numes M, Zukerman E (2006) Chronic migraine prevention with topiramate. J Headache Pain 7:185-187
9. Silvestrini M, Bartolini M, Coccia M et al (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23:820-824
10. Diener HC, Goadsby PJ, Bussone G et al (2006) Assessing the efficacy and safety of topiramate for the prevention of chronic migraine. J Headache Pain 7[Suppl 1]:S45-S46
11. Brandes J, Saper JR, Diamond M et al (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
12. Diener HC, Tfelt-Hansen P, Dahlof C et al (2004) Topiramate in migraine prophylaxis. Results from a placebocontrolled trial with propranolol as active control. J Neurol 251:943-950
13. Silberstein SD, Neto W, Schmitt JJ, Jacobs D (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495